DFine Release: RF-TVA Therapy Offers Hope for Patients Suffering from Osteoporosis-Related Spine Fractures

SAN JOSE, Calif.--(BUSINESS WIRE)--In observance of National Osteoporosis Awareness Month in May, DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, encourages patients to learn about the risks of spine fractures and the latest treatment options available.

MORE ON THIS TOPIC